Kansas City Cancer Center (KCCC), an affiliate of US Oncology, Inc. which supports the nation's foremost cancer treatment and research network, has treated its first patient with the new TomoTherapy(R) radiation therapy technology at its new KCCC-Shawnee Mission office.
KCCC is the only healthcare provider in the greater Kansas City metropolitan area with a TomoTherapy treatment machine - a welcomed new treatment that combines CT imaging with conformal radiation therapy. Used to treat a wide variety of cancers, KCCC's use of the TomoTherapy Hi Art((R)) treatment system is delivering radiation with pinpoint accuracy. According to Radiation Oncologist James Coster, M.D., this form of external beam radiation will protect patients from the harm that results from killing more than just the cancer.
"It's so precise that radiation can be localized to the cancer itself while nearly eliminating the dose to the surrounding healthy tissues," says Coster. "It completely changes the way we fight cancers of the head, neck, breast and prostate, and the impact we can make on overall patient health."